These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2888675)

  • 1. Transforming growth factor type beta can act as a potent competence factor for AKR-2B cells.
    Goustin AS; Nuttall GA; Leof EB; Ranganathan G; Moses HL
    Exp Cell Res; 1987 Oct; 172(2):293-303. PubMed ID: 2888675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of N,N-dimethylformamide and retinoic acid on transforming growth factor-beta induced mitogenesis in AKR-2B mouse embryo fibroblasts.
    Levine AE; Crandall CA
    Cancer Res; 1987 Aug; 47(16):4278-82. PubMed ID: 3496961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.
    Coffey RJ; Leof EB; Shipley GD; Moses HL
    J Cell Physiol; 1987 Jul; 132(1):143-8. PubMed ID: 3496343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta and retinoic acid modulate phenotypic transformation of normal rat kidney cells induced by epidermal growth factor and platelet-derived growth factor.
    van Zoelen EJ; van Oostwaard TM; de Laat SW
    J Biol Chem; 1986 Apr; 261(11):5003-9. PubMed ID: 3007486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type beta transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval.
    Shipley GD; Tucker RF; Moses HL
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4147-51. PubMed ID: 3858871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of growth inhibitory activity in transformed mouse embryo fibroblasts.
    Levine AE; Crandall CA; Brattain MG
    Exp Cell Res; 1987 Aug; 171(2):357-66. PubMed ID: 2887448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets.
    Tucker RF; Branum EL; Shipley GD; Ryan RJ; Moses HL
    Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6757-61. PubMed ID: 6208555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming and nontransforming growth factors are present in medium conditioned by fetal rat calvariae.
    Centrella M; Canalis E
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7335-9. PubMed ID: 2997787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor.
    Carr BI; Hayashi I; Branum EL; Moses HL
    Cancer Res; 1986 May; 46(5):2330-4. PubMed ID: 3008986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1.
    Keski-Oja J; Lyons RM; Moses HL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6451-8. PubMed ID: 2890433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels.
    Mioh H; Chen JK
    J Cell Physiol; 1989 Jun; 139(3):509-16. PubMed ID: 2472412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmin cleaves betaglycan and releases a 60 kDa transforming growth factor-beta complex from the cell surface.
    Lamarre J; Vasudevan J; Gonias SL
    Biochem J; 1994 Aug; 302 ( Pt 1)(Pt 1):199-205. PubMed ID: 8068006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta 1 treatment of AKR-2B cells is coupled through a pertussis-toxin-sensitive G-protein(s).
    Howe PH; Leof EB
    Biochem J; 1989 Aug; 261(3):879-86. PubMed ID: 2508623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells.
    Tucker RF; Volkenant ME; Branum EL; Moses HL
    Cancer Res; 1983 Apr; 43(4):1581-6. PubMed ID: 6299525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta controls receptor levels for epidermal growth factor in NRK fibroblasts.
    Assoian RK; Frolik CA; Roberts AB; Miller DM; Sporn MB
    Cell; 1984 Jan; 36(1):35-41. PubMed ID: 6319010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative stimulation of specific gene transcription by epidermal growth factor and transforming growth factor type beta 1.
    Ranganathan G; Getz MJ
    J Biol Chem; 1990 Feb; 265(6):3001-4. PubMed ID: 2105937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of glucose uptake by transforming growth factor beta: evidence for the requirement of epidermal growth factor-receptor activation.
    Inman WH; Colowick SP
    Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1346-9. PubMed ID: 2983339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the mitogenic response of an epidermal growth factor-dependent keratinocyte cell line by dexamethasone, insulin, and transforming growth factor-beta.
    Zendegui JG; Inman WH; Carpenter G
    J Cell Physiol; 1988 Aug; 136(2):257-65. PubMed ID: 2457593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a serum-free culture system comparing growth factor requirements of transformed and untransformed cells.
    Mulder KM; Childress-Fields KE
    Exp Cell Res; 1990 Jun; 188(2):254-61. PubMed ID: 2185944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coupling of TGF-beta-induced mitogenesis to G-protein activation in AKR-2B cells.
    Murthy US; Anzano MA; Stadel JM; Greig R
    Biochem Biophys Res Commun; 1988 May; 152(3):1228-35. PubMed ID: 3132155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.